drugset / Trial / NCT04905953
Comparison Of Different Doses Of Intrathecal Neostigmine In Prevention Of Post-Dural Puncture Headache
RandomizedParallel-groupOpen-labelPrevention
Summary
We hypothesized that; intrathecal administration of neostgmine in spinal anesthesia may have a beneficial role in reduction of the incidence or severity of PDPH.
Timeline
- Start
- 2021-02-01
- Primary completion
- 2022-02-01
- Completion
- 2022-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neostigmine | Other / unclassified | 10 ug | Intrathecal |
| Subject | Neostigmine | Other / unclassified | 20 ug | Intrathecal |